US 12,343,306 B2
Ready-to-sell packaging unit containing at least one pharmaceutical product, set including a plurality of such packaging units and method for producing such packaging unit
Christophe DeJonghe, Ecully (FR); Ludovic Giroud, Marcy l'Etoile (FR); Teddy Klein, Villefontaine (FR); and Philippe Revolte, Saint-Genis-Laval (FR)
Assigned to Sanofi Pasteur, Lyons (FR)
Appl. No. 17/263,334
Filed by Sanofi Pasteur, Lyons (FR)
PCT Filed Jul. 26, 2019, PCT No. PCT/EP2019/070244
§ 371(c)(1), (2) Date Jan. 26, 2021,
PCT Pub. No. WO2020/021095, PCT Pub. Date Jan. 30, 2020.
Claims priority of application No. 18306021 (EP), filed on Jul. 27, 2018.
Prior Publication US 2021/0186809 A1, Jun. 24, 2021
Int. Cl. A61J 1/05 (2006.01); B65D 5/42 (2006.01); B65D 5/66 (2006.01); B65D 77/04 (2006.01)
CPC A61J 1/05 (2013.01) [B65D 5/4204 (2013.01); B65D 5/4233 (2013.01); B65D 5/6611 (2013.01); B65D 77/042 (2013.01); A61J 2205/50 (2013.01)] 22 Claims
OG exemplary drawing
 
1. A set of packaging units including a first ready-to-sell packaging unit and a second ready-to-sell packaging unit, each of the first and second ready-to-sell packaging units containing at least one pharmaceutical product and comprising:
an inner enclosure within which the at least one pharmaceutical product is contained;
a patient or health care professional information leaflet; and
an outer enclosure within which the inner enclosure and the information leaflet are contained, the outer enclosure being provided with labelling features, with traceability and anti-counterfeiting features, and with anti-tampering features of the ready-to-sell packaging unit,
wherein the outer enclosure includes:
a first outer enclosure within which the inner enclosure is contained, the first outer enclosure being provided with the traceability and anti-counterfeiting features and with the anti-tampering features, the information leaflet being outside of the first outer enclosure; and
a second outer enclosure within which the first outer enclosure and the information leaflet are contained, the second outer enclosure being provided with the labelling features, the second outer enclosure having an opening, the opening and the traceability and anti-counterfeiting features being arranged so that the traceability and anti-counterfeiting features are visible through the opening;
wherein the pharmaceutical product and the first outer enclosure are identical for the first ready-to-sell packaging unit and the second ready-to-sell packaging unit, whereas the information leaflet and the second outer enclosure are different for the first ready-to-sell packaging unit and the second ready-to-sell packaging unit and customized to respective requirements of markets in which the first and second ready-to-sell packaging units are to be sold.